{"id":"https://openalex.org/W7166803282","doi":"https://doi.org/10.1080/14760584.2026.2689614","title":"Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit\u2013cost analysis","display_name":"Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit\u2013cost analysis","publication_year":2026,"publication_date":"2026-07-01","ids":{"openalex":"https://openalex.org/W7166803282","doi":"https://doi.org/10.1080/14760584.2026.2689614","pmid":"https://pubmed.ncbi.nlm.nih.gov/42384548"},"language":"en","primary_location":{"id":"doi:10.1080/14760584.2026.2689614","doi":"https://doi.org/10.1080/14760584.2026.2689614","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14760584.2026.2689614","pdf_url":null,"source":{"id":"https://openalex.org/S163950488","display_name":"Expert Review of Vaccines","issn_l":"1476-0584","issn":["1476-0584","1744-8395"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Vaccines","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1080/14760584.2026.2689614","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5135998878","display_name":"Ellie Tunnicliffe","orcid":"https://orcid.org/0009-0006-5236-5054","observed_orcids":["https://orcid.org/0009-0006-5236-5054"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ellie Tunnicliffe","raw_affiliation_strings":["Office of Health Economics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026468558","display_name":"Matthew Napier","orcid":"https://orcid.org/0009-0003-3033-5418","observed_orcids":["https://orcid.org/0009-0003-3033-5418"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew Napier","raw_affiliation_strings":["Office of Health Economics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115011405","display_name":"Claud Theakston","orcid":"https://orcid.org/0009-0008-6876-1523","observed_orcids":["https://orcid.org/0009-0008-6876-1523"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Claud Theakston","raw_affiliation_strings":["Office of Health Economics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139753407","display_name":"Soo Chin Yen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Soo Chin Yen","raw_affiliation_strings":["Office of Health Economics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121444858","display_name":"Sukanya Subramaniyan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sukanya Subramaniyan","raw_affiliation_strings":["Office of Health Economics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017155931","display_name":"Simon Brassel","orcid":"https://orcid.org/0000-0001-7574-9671","observed_orcids":["https://orcid.org/0000-0001-7574-9671"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Simon Brassel","raw_affiliation_strings":["Office of Health Economics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101774258","display_name":"Fredrik Olof Laurentius Nilsson","orcid":"https://orcid.org/0000-0002-1905-4047","observed_orcids":["https://orcid.org/0000-0002-1905-4047","https://orcid.org/0000-0002-5225-5174"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fredrik Nilsson","raw_affiliation_strings":["Pfizer AB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer AB","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138168394","display_name":"Katherina Zakikhany-Gilg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherina Zakikhany-Gilg","raw_affiliation_strings":["Pfizer AB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer AB","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074086863","display_name":"Andreas Palmborg","orcid":"https://orcid.org/0000-0002-4833-112X","observed_orcids":["https://orcid.org/0000-0002-4833-112X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Palmborg","raw_affiliation_strings":["Pfizer AB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer AB","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024904306","display_name":"M\u00e1t\u00e9 Szilcz","orcid":"https://orcid.org/0000-0002-9291-0559","observed_orcids":["https://orcid.org/0000-0002-9291-0559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mate Szilcz","raw_affiliation_strings":["Viti Science AB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Viti Science AB","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063309950","display_name":"Samira Toghanian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samira Toghanian","raw_affiliation_strings":["Pfizer AB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer AB","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014316182","display_name":"Pontus Hedberg","orcid":"https://orcid.org/0000-0003-3153-098X","observed_orcids":["https://orcid.org/0000-0003-3153-098X"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Pontus Hedberg","raw_affiliation_strings":["Karolinska Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karolinska Institute","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010583076","display_name":"Mikael Svensson","orcid":"https://orcid.org/0000-0003-1113-7478","observed_orcids":["https://orcid.org/0000-0003-1113-7478"]},"institutions":[{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mikael Svensson","raw_affiliation_strings":["University of Gothenburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Gothenburg","institution_ids":["https://openalex.org/I881427289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021610597","display_name":"Tianyan Hu","orcid":"https://orcid.org/0009-0004-2660-8871","observed_orcids":["https://orcid.org/0009-0004-2660-8871"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tianyan Hu","raw_affiliation_strings":["Pfizer Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139718693","display_name":"Jingyan Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingyan Yang","raw_affiliation_strings":["Pfizer Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087861262","display_name":"Lotte Steuten","orcid":"https://orcid.org/0000-0002-5688-236X","observed_orcids":["https://orcid.org/0000-0002-5688-236X"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lotte Steuten","raw_affiliation_strings":["Office of Health Economics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics","institution_ids":["https://openalex.org/I4210092722"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5017155931"],"corresponding_institution_ids":["https://openalex.org/I4210092722"],"apc_list":null,"apc_paid":null,"fwci":4.3524,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.88658645,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"25","issue":"1","first_page":"2689614","last_page":"2689614"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8759999871253967,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8759999871253967,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.04399999976158142,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.04100000113248825,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pneumococcal-vaccination","display_name":"pneumococcal vaccination","score":0.9089999794960022},{"id":"https://openalex.org/keywords/influenza-vaccination","display_name":"influenza vaccination","score":0.843999981880188},{"id":"https://openalex.org/keywords/covid-19-vaccination","display_name":"COVID-19 vaccination","score":0.949999988079071},{"id":"https://openalex.org/keywords/respiratory-syncytial-virus-vaccination","display_name":"respiratory syncytial virus vaccination","score":0.9620000123977661},{"id":"https://openalex.org/keywords/vaccine-uptake","display_name":"vaccine uptake","score":0.8809999823570251},{"id":"https://openalex.org/keywords/vaccination-coverage","display_name":"vaccination coverage","score":0.49399998784065247},{"id":"https://openalex.org/keywords/benefit-cost-ratio","display_name":"benefit-cost ratio","score":0.6840000152587891},{"id":"https://openalex.org/keywords/net-benefit","display_name":"net benefit","score":0.7829999923706055},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.7059999704360962},{"id":"https://openalex.org/keywords/clinical-risk-groups","display_name":"clinical risk groups","score":0.8069999814033508},{"id":"https://openalex.org/keywords/value-of-a-statistical-life","display_name":"value of a statistical life","score":0.6190000176429749},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.8759999871253967},{"id":"https://openalex.org/keywords/sweden","display_name":"Sweden","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6894000172615051},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.6061000227928162},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5752999782562256},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.5432999730110168},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.41620001196861267},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.33570000529289246},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.321399986743927},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.31679999828338623},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3102000057697296},{"id":"https://openalex.org/C2994330797","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory illness","level":3,"score":0.3021000027656555},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2892000079154968},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.2888999879360199},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.2676999866962433},{"id":"https://openalex.org/C2993183539","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory infection","level":3,"score":0.26660001277923584},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26170000433921814},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.25940001010894775},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.25850000977516174},{"id":"https://openalex.org/C2776012195","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory tract infections","level":3,"score":0.25699999928474426},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.25679999589920044},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.25369998812675476},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.25200000405311584}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007251","descriptor_name":"Influenza, Human","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007251","descriptor_name":"Influenza, Human","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011008","descriptor_name":"Pneumococcal Infections","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011008","descriptor_name":"Pneumococcal Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D017589","descriptor_name":"Immunization Programs","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D018357","descriptor_name":"Respiratory Syncytial Virus Infections","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D018357","descriptor_name":"Respiratory Syncytial Virus Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D022242","descriptor_name":"Pneumococcal Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D022242","descriptor_name":"Pneumococcal Vaccines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/14760584.2026.2689614","doi":"https://doi.org/10.1080/14760584.2026.2689614","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14760584.2026.2689614","pdf_url":null,"source":{"id":"https://openalex.org/S163950488","display_name":"Expert Review of Vaccines","issn_l":"1476-0584","issn":["1476-0584","1744-8395"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Vaccines","raw_type":"journal-article"},{"id":"pmid:42384548","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42384548","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of vaccines","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:34718cf5c32a4cfaa41959fea71ce633","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/34718cf5c32a4cfaa41959fea71ce633","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Review of Vaccines, Vol 25, Iss 1 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/14760584.2026.2689614","doi":"https://doi.org/10.1080/14760584.2026.2689614","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14760584.2026.2689614","pdf_url":null,"source":{"id":"https://openalex.org/S163950488","display_name":"Expert Review of Vaccines","issn_l":"1476-0584","issn":["1476-0584","1744-8395"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Vaccines","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W2048915310","https://openalex.org/W2092545077","https://openalex.org/W2612737944","https://openalex.org/W2953804899","https://openalex.org/W3029825247","https://openalex.org/W3047366239","https://openalex.org/W3048678908","https://openalex.org/W3181487322","https://openalex.org/W3201135093","https://openalex.org/W4210842666","https://openalex.org/W4220918132","https://openalex.org/W4248050199","https://openalex.org/W4295067408","https://openalex.org/W4361279813","https://openalex.org/W4362603786","https://openalex.org/W4383531877","https://openalex.org/W4389088085","https://openalex.org/W4394824789","https://openalex.org/W4401090798","https://openalex.org/W4404263150","https://openalex.org/W4405542578","https://openalex.org/W4406221882","https://openalex.org/W4407302701","https://openalex.org/W4412500099","https://openalex.org/W4412500262","https://openalex.org/W4412877894","https://openalex.org/W4413350821","https://openalex.org/W4415546230","https://openalex.org/W7128601044","https://openalex.org/W7162509605"],"related_works":["https://openalex.org/W4412500099","https://openalex.org/W7222871141","https://openalex.org/W7166888547","https://openalex.org/W7170075625","https://openalex.org/W7160908153","https://openalex.org/W6921172396","https://openalex.org/W7122408282","https://openalex.org/W4417460595","https://openalex.org/W7166019571","https://openalex.org/W2956138588"],"abstract_inverted_index":{"BACKGROUND:":[0],"In":[1],"Sweden,":[2,131],"older":[3,105],"adults":[4,6,106],"and":[5,21,73,84,93,98,111,167,193],"in":[7,104,130,157],"clinical":[8],"risk":[9,122],"groups":[10,123],"are":[11],"recommended":[12],"vaccination":[13,89,189],"against":[14],"pneumococcal":[15],"disease,":[16],"respiratory":[17,155],"syncytial":[18],"virus,":[19],"influenza,":[20],"COVID-19.":[22],"However,":[23],"vaccine":[24],"uptake":[25],"remains":[26],"inadequate.":[27],"This":[28],"study":[29],"estimates":[30],"the":[31,46,82,163],"socioeconomic":[32],"benefits":[33,75,171],"of":[34,109,113],"these":[35],"immunization":[36],"programs":[37,103],"under":[38,174],"current":[39,128],"coverage":[40,97,140],"compared":[41],"to":[42,50,68,126,134,185],"aspirational":[43,139],"scenarios,":[44],"assessing":[45],"value":[47,161],"foregone":[48],"due":[49],"suboptimal":[51],"uptake.":[52],"METHODS:":[53],"We":[54],"conducted":[55],"a":[56,60,118],"benefit-cost":[57,70],"analysis":[58],"from":[59],"societal":[61],"perspective":[62],"applying":[63],"life":[64],"table-based":[65],"disease":[66],"models":[67],"estimate":[69],"ratios":[71],"(BCRs)":[72],"net":[74],"(NBs).":[76],"Health":[77],"impacts":[78],"were":[79,124],"monetized":[80],"through":[81],"value-of-a-statistical-life":[83],"cost-of-illness":[85],"approaches.":[86],"Costs":[87],"comprised":[88],"program":[90,99],"expenses.":[91],"Scenario":[92],"sensitivity":[94],"analyses":[95],"explore":[96],"eligibility.":[100],"RESULTS:":[101],"Vaccination":[102],"generated":[107],"BCRs":[108],"3:1":[110],"NBs":[112,132,143,150],"SEK":[114,135],"54.4":[115],"billion":[116],"over":[117],"lifetime":[119],"(VSLY).":[120],"When":[121],"included":[125],"model":[127],"strategies":[129,184],"increased":[133,142],"59.7":[136],"billion.":[137],"Reaching":[138],"targets":[141],"by":[144,151],"18%,":[145],"meanwhile":[146],"restricting":[147],"eligibility":[148],"reduced":[149],"64%.":[152],"CONCLUSION:":[153],"Adult":[154],"vaccinations":[156],"Sweden":[158],"provide":[159],"substantial":[160],"for":[162],"healthcare":[164],"system,":[165],"economy":[166],"society,":[168],"with":[169],"estimated":[170],"exceeding":[172],"costs":[173],"modeled":[175],"assumptions.":[176],"These":[177],"findings":[178],"may":[179],"inform":[180],"policy":[181],"discussions":[182],"on":[183],"sustain":[186],"or":[187],"expand":[188],"budgets,":[190],"improve":[191],"access":[192],"increase":[194],"uptake,":[195],"particularly":[196],"among":[197],"at-risk":[198],"populations.":[199]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-07-02T00:00:00"}